chr12-111569952-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001372574.1(ATXN2):​c.252-14033G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.675 in 152,086 control chromosomes in the GnomAD database, including 37,625 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 37625 hom., cov: 32)

Consequence

ATXN2
NM_001372574.1 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.11

Publications

315 publications found
Variant links:
Genes affected
ATXN2 (HGNC:10555): (ataxin 2) This gene belongs to a group of genes that is associated with microsatellite-expansion diseases, a class of neurological and neuromuscular disorders caused by expansion of short stretches of repetitive DNA. The protein encoded by this gene has two globular domains near the N-terminus, one of which contains a clathrin-mediated trans-Golgi signal and an endoplasmic reticulum exit signal. The encoded cytoplasmic protein localizes to the endoplasmic reticulum and plasma membrane, is involved in endocytosis, and modulates mTOR signals, modifying ribosomal translation and mitochondrial function. The N-terminal region of the protein contains a polyglutamine tract of 14-31 residues that can be expanded in the pathogenic state to 32-200 residues. Intermediate length expansions of this tract increase susceptibility to amyotrophic lateral sclerosis, while long expansions of this tract result in spinocerebellar ataxia-2, an autosomal-dominantly inherited, neurodegenerative disorder. Genome-wide association studies indicate that loss-of-function mutations in this gene may be associated with susceptibility to type I diabetes, obesity and hypertension. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
ATXN2 Gene-Disease associations (from GenCC):
  • spinocerebellar ataxia type 2
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.99).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001372574.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
NM_001372574.1
MANE Select
c.252-14033G>A
intron
N/ANP_001359503.1
ATXN2
NM_002973.4
c.252-14033G>A
intron
N/ANP_002964.4
ATXN2
NM_001310121.1
c.-64-14033G>A
intron
N/ANP_001297050.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATXN2
ENST00000673436.1
MANE Select
c.252-14033G>A
intron
N/AENSP00000500925.1
ATXN2
ENST00000550104.5
TSL:1
c.732-14033G>A
intron
N/AENSP00000446576.2
ATXN2
ENST00000608853.5
TSL:1
c.252-14033G>A
intron
N/AENSP00000476504.1

Frequencies

GnomAD3 genomes
AF:
0.675
AC:
102532
AN:
151968
Hom.:
37550
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.918
Gnomad AMI
AF:
0.540
Gnomad AMR
AF:
0.706
Gnomad ASJ
AF:
0.329
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.906
Gnomad FIN
AF:
0.593
Gnomad MID
AF:
0.631
Gnomad NFE
AF:
0.512
Gnomad OTH
AF:
0.647
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.675
AC:
102671
AN:
152086
Hom.:
37625
Cov.:
32
AF XY:
0.687
AC XY:
51069
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.918
AC:
38104
AN:
41514
American (AMR)
AF:
0.707
AC:
10784
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.329
AC:
1143
AN:
3470
East Asian (EAS)
AF:
0.998
AC:
5172
AN:
5182
South Asian (SAS)
AF:
0.906
AC:
4373
AN:
4826
European-Finnish (FIN)
AF:
0.593
AC:
6260
AN:
10564
Middle Eastern (MID)
AF:
0.630
AC:
184
AN:
292
European-Non Finnish (NFE)
AF:
0.512
AC:
34787
AN:
67958
Other (OTH)
AF:
0.651
AC:
1374
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1424
2848
4272
5696
7120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
778
1556
2334
3112
3890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.565
Hom.:
93439
Bravo
AF:
0.689
Asia WGS
AF:
0.943
AC:
3279
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.99
CADD
Benign
0.10
DANN
Benign
0.33
PhyloP100
-2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs653178; hg19: chr12-112007756; API